Screener
Regeneron Pharmaceuticals REGN Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $65.37B.
The source filing: Regeneron Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 6:52 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000872589-26-000025
FAQ
- What is Regeneron Pharmaceuticals's market capitalization?
- Regeneron Pharmaceuticals (REGN) reported market capitalization of $65.37B in Q2 2026.
- How has Regeneron Pharmaceuticals's market capitalization changed year-over-year?
- Regeneron Pharmaceuticals's market capitalization increased by 15.9% year-over-year, from $56.39B to $65.37B.
- What is the long-term trend for Regeneron Pharmaceuticals's market capitalization?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's market capitalization has grown at a 9.3% compound annual growth rate (CAGR), from $51.96B to $81.12B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Regeneron Pharmaceuticals's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude